Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DexCom Inc (NASDAQ:DXCM)

73.20
Delayed Data
As of Aug 18
 +0.42 / +0.58%
Today’s Change
57.68
Today|||52-Week Range
96.38
+22.61%
Year-to-Date
No recent news for DexCom Inc.

Today’s Trading

Previous close72.78
Today’s open72.58
Day’s range72.13 - 74.49
Volume1,234,880
Average volume (3 months)1,174,672
Market cap$6.3B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-8.33%
Earnings growth (this year)+8.57%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+42.61%
P/E ratioNM
Price/Sales8.71
Price/Book21.82

Competitors

 Today’s
change
Today’s
% change
WSTWest Pharmaceutical ...-0.16-0.19%
ABMDAbiomed Inc-1.56-1.01%
MASIMasimo Corp-1.47-1.68%
IARTIntegra LifeSciences...+0.56+1.13%
Data as of 4:02pm ET, 08/18/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$573.3M
Annual profit (last year)-$65.6M
Net profit margin-11.44%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin Ronald Sayer
Senior Vice President-
Operations
Jeffrey C. Moy
Corporate headquarters
San Diego, California

Forecasts